COCP•benzinga•
Cocrystal Pharma Announces Norovirus Oral Antiviral Candidate Demonstrates Potent Activity Against The Emerging GII.17 Variants
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 24, 2025 by benzinga